A phase 3 study demonstrated that ritlecitinib was effective and well tolerated in patients with alopecia areata and ≥ 25% ...
GlobalData on MSN20h
Alys Pharmaceuticals receives regulatory approvals for alopaecia areata drug trialUS-based immuno-dermatology company Alys Pharmaceuticals has received clearance from the US Food and Drug Administration (FDA ...
Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the international CorEvitas Adolescent Alopecia Areata (AA) Registry, addressing a critical unmet need ...
But one woman just shattered that illusion in the most stunning way possible. Neehar Sachdeva, a US-based fashion influencer, ...
Panelists discuss how the data from the BRAVE-AA1 and BRAVE-AA2 phase 3 trials demonstrated the safety and efficacy of baricitinib, leading to its FDA approval in 2022 as the first systemic treatment ...
Neehar Sachdeva, a US-based fashion influencer, is redefining beauty standards. Diagnosed with alopecia areata –– an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback